Literature DB >> 25650940

Alzheimer's protective A2T mutation changes the conformational landscape of the Aβ₁₋₄₂ monomer differently than does the A2V mutation.

Payel Das1, Brian Murray2, Georges Belfort2.   

Abstract

The aggregation of amyloid-β (Aβ) peptides plays a crucial role in the etiology of Alzheimer's disease (AD). Recently, it has been reported that an A2T mutation in Aβ can protect against AD. Interestingly, a nonpolar A2V mutation also has been found to offer protection against AD in the heterozygous state, although it causes early-onset AD in homozygous carriers. Since the conformational landscape of the Aβ monomer is known to directly contribute to the early-stage aggregation mechanism, it is important to characterize the effects of the A2T and A2V mutations on Aβ₁₋₄₂ monomer structure. Here, we have performed extensive atomistic replica-exchange molecular dynamics simulations of the solvated wild-type (WT), A2V, and A2T Aβ₁₋₄₂ monomers. Our simulations reveal that although all three variants remain as collapsed coils in solution, there exist significant structural differences among them at shorter timescales. A2V exhibits an enhanced double-hairpin population in comparison to the WT, similar to those reported in toxic WT Aβ₁₋₄₂ oligomers. Such double-hairpin formation is caused by hydrophobic clustering between the N-terminus and the central and C-terminal hydrophobic patches. In contrast, the A2T mutation causes the N-terminus to engage in unusual electrostatic interactions with distant residues, such as K16 and E22, resulting in a unique population comprising only the C-terminal hairpin. These findings imply that a single A2X (where X = V or T) mutation in the primarily disordered N-terminus of the Aβ₁₋₄₂ monomer can dramatically alter the β-hairpin population and switch the equilibrium toward alternative structures. The atomistically detailed, comparative view of the structural landscapes of A2V and A2T variant monomers obtained in this study can enhance our understanding of the mechanistic differences in their early-stage aggregation.
Copyright © 2015 Biophysical Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25650940      PMCID: PMC4317528          DOI: 10.1016/j.bpj.2014.12.013

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  80 in total

1.  On the nucleation of amyloid beta-protein monomer folding.

Authors:  Noel D Lazo; Marianne A Grant; Margaret C Condron; Alan C Rigby; David B Teplow
Journal:  Protein Sci       Date:  2005-06       Impact factor: 6.725

2.  The Alzheimer disease protective mutation A2T modulates kinetic and thermodynamic properties of amyloid-β (Aβ) aggregation.

Authors:  Iryna Benilova; Rodrigo Gallardo; Andreea-Alexandra Ungureanu; Virginia Castillo Cano; An Snellinx; Meine Ramakers; Carmen Bartic; Frederic Rousseau; Joost Schymkowitz; Bart De Strooper
Journal:  J Biol Chem       Date:  2014-09-24       Impact factor: 5.157

3.  Identification of a mutant amyloid peptide that predominantly forms neurotoxic protofibrillar aggregates.

Authors:  Isam Qahwash; Katherine L Weiland; Yifeng Lu; Ronald W Sarver; Rolf F Kletzien; Riqiang Yan
Journal:  J Biol Chem       Date:  2003-04-08       Impact factor: 5.157

Review 4.  Amyloid oligomers: formation and toxicity of Abeta oligomers.

Authors:  Masafumi Sakono; Tamotsu Zako
Journal:  FEBS J       Date:  2010-02-09       Impact factor: 5.542

5.  pH-dependent conformations of the amyloid beta(1-28) peptide fragment explored using molecular dynamics.

Authors:  K Kirshenbaum; V Daggett
Journal:  Biochemistry       Date:  1995-06-13       Impact factor: 3.162

Review 6.  Pyroglutamate amyloid-β (Aβ): a hatchet man in Alzheimer disease.

Authors:  Sadim Jawhar; Oliver Wirths; Thomas A Bayer
Journal:  J Biol Chem       Date:  2011-09-29       Impact factor: 5.157

7.  FcγRIIb mediates amyloid-β neurotoxicity and memory impairment in Alzheimer's disease.

Authors:  Tae-In Kam; Sungmin Song; Youngdae Gwon; Hyejin Park; Ji-Jing Yan; Isak Im; Ji-Woo Choi; Tae-Yong Choi; Jeongyeon Kim; Dong-Keun Song; Toshiyuki Takai; Yong-Chul Kim; Key-Sun Kim; Se-Young Choi; Sukwoo Choi; William L Klein; Junying Yuan; Yong-Keun Jung
Journal:  J Clin Invest       Date:  2013-06-10       Impact factor: 14.808

8.  The structure of the Alzheimer amyloid beta 10-35 peptide probed through replica-exchange molecular dynamics simulations in explicit solvent.

Authors:  Andrij Baumketner; Joan-Emma Shea
Journal:  J Mol Biol       Date:  2006-11-10       Impact factor: 5.469

9.  Aβ monomers transiently sample oligomer and fibril-like configurations: ensemble characterization using a combined MD/NMR approach.

Authors:  David J Rosenman; Christopher R Connors; Wen Chen; Chunyu Wang; Angel E García
Journal:  J Mol Biol       Date:  2013-06-25       Impact factor: 5.469

10.  Expression of A2V-mutated Aβ in Caenorhabditis elegans results in oligomer formation and toxicity.

Authors:  Luisa Diomede; Giuseppe Di Fede; Margherita Romeo; Renzo Bagnati; Roberta Ghidoni; Fabio Fiordaliso; Monica Salio; Alessandro Rossi; Marcella Catania; Anna Paterlini; Luisa Benussi; Antonio Bastone; Matteo Stravalaci; Marco Gobbi; Fabrizio Tagliavini; Mario Salmona
Journal:  Neurobiol Dis       Date:  2013-11-01       Impact factor: 5.996

View more
  19 in total

1.  Conformational Ensembles of the Wild-Type and S8C Aβ1-42 Dimers.

Authors:  Viet Hoang Man; Phuong H Nguyen; Philippe Derreumaux
Journal:  J Phys Chem B       Date:  2017-03-10       Impact factor: 2.991

2.  Exploring the aggregation free energy landscape of the amyloid-β protein (1-40).

Authors:  Weihua Zheng; Min-Yeh Tsai; Mingchen Chen; Peter G Wolynes
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-03       Impact factor: 11.205

3.  How accurate are your simulations? Effects of confined aqueous volume and AMBER FF99SB and CHARMM22/CMAP force field parameters on structural ensembles of intrinsically disordered proteins: Amyloid-β42 in water.

Authors:  Orkid Coskuner Weber; Vladimir N Uversky
Journal:  Intrinsically Disord Proteins       Date:  2017-10-30

4.  Pyroglutamate-Modified Amyloid-β(3-42) Shows α-Helical Intermediates before Amyloid Formation.

Authors:  Christina Dammers; Kerstin Reiss; Lothar Gremer; Justin Lecher; Tamar Ziehm; Matthias Stoldt; Melanie Schwarten; Dieter Willbold
Journal:  Biophys J       Date:  2017-04-25       Impact factor: 4.033

Review 5.  Insights into the Molecular Mechanisms of Alzheimer's and Parkinson's Diseases with Molecular Simulations: Understanding the Roles of Artificial and Pathological Missense Mutations in Intrinsically Disordered Proteins Related to Pathology.

Authors:  Orkid Coskuner-Weber; Vladimir N Uversky
Journal:  Int J Mol Sci       Date:  2018-01-24       Impact factor: 5.923

6.  High-Resolution Structures of the Amyloid-β 1-42 Dimers from the Comparison of Four Atomistic Force Fields.

Authors:  Viet Hoang Man; Phuong H Nguyen; Philippe Derreumaux
Journal:  J Phys Chem B       Date:  2017-06-07       Impact factor: 2.991

7.  Amyloid β-Protein Assembly: Differential Effects of the Protective A2T Mutation and Recessive A2V Familial Alzheimer's Disease Mutation.

Authors:  Xueyun Zheng; Deyu Liu; Robin Roychaudhuri; David B Teplow; Michael T Bowers
Journal:  ACS Chem Neurosci       Date:  2015-08-12       Impact factor: 4.418

8.  Acetylation of Aβ40 Alters Aggregation in the Presence and Absence of Lipid Membranes.

Authors:  Albert W Pilkington; Jane Schupp; Morgan Nyman; Stephen J Valentine; David M Smith; Justin Legleiter
Journal:  ACS Chem Neurosci       Date:  2019-12-27       Impact factor: 4.418

9.  Allosteric stabilization of the amyloid-β peptide hairpin by the fluctuating N-terminal.

Authors:  Liang Xu; Ruth Nussinov; Buyong Ma
Journal:  Chem Commun (Camb)       Date:  2015-12-15       Impact factor: 6.222

10.  Amylin-Aβ oligomers at atomic resolution using molecular dynamics simulations: a link between Type 2 diabetes and Alzheimer's disease.

Authors:  Michal Baram; Yoav Atsmon-Raz; Buyong Ma; Ruth Nussinov; Yifat Miller
Journal:  Phys Chem Chem Phys       Date:  2016-01-28       Impact factor: 3.676

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.